Distributional Balancing with Machine Learning for Clinical Trial Augmentation Using Real-World Data
利用机器学习实现分布平衡:以真实世界数据增强临床试验AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要以临床试验外部对照构建和治疗效应估计所需的协变量平衡为背景,最直接对应因果推断方向。
利用机器学习实现分布平衡:以真实世界数据增强临床试验AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
In clinical trials, randomization of treatment and control groups is typically used to ensure the groups have similar covariate distributions on average, resulting in unbiased causal effect estimation. Such balanced covariate distributions are hard to achieve in practice, however, due to recruitment costs, patient dropouts, and more. One possible solution to this problem is to include control patients from external, real world databases. In this paper, we propose DBML, a method that selects control units from a real world database by matching the distribution between the treatment group and the potential control group, instead of matching units between two groups. DBML has three steps. First, we detect anomalous database units (with respect to the treatment distribution) using a variational autoencoder. Second, we re-weight the remaining database units to match the distribution of the treatments. Finally, we use these weights to sample units for our control group. The proposed method is compared to alternative matching-based algorithms and weighted algorithms, achieving superior performance in covariate balance.